261 related articles for article (PubMed ID: 27397087)
1. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
2. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
3. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
4. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
[TBL] [Abstract][Full Text] [Related]
5. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
6. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.
Ma Y; Wang J; Guo S; Meng Z; Ren Y; Xie Y; Wang M
Front Immunol; 2022; 13():1064007. PubMed ID: 36761173
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis.
Zeng C; Chen L; Chen B; Cai Y; Li P; Yan L; Zeng D
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1266-1273. PubMed ID: 30418472
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
9. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.
Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224
[TBL] [Abstract][Full Text] [Related]
10. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
11. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.
Kothur K; Gill D; Wong M; Mohammad SS; Bandodkar S; Arbunckle S; Wienholt L; Dale RC
Dev Med Child Neurol; 2017 Aug; 59(8):806-814. PubMed ID: 28439892
[TBL] [Abstract][Full Text] [Related]
14. Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13.
Fujimori J; Takahashi T; Kaneko K; Atobe Y; Nakashima I
Mult Scler Relat Disord; 2021 Jan; 47():102611. PubMed ID: 33160141
[TBL] [Abstract][Full Text] [Related]
15. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
16. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
17. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit.
Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X
Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725
[TBL] [Abstract][Full Text] [Related]
18. Absence of serum anti-NMDAR antibodies in anti-NMDAR encephalitis mother predicts having healthy newborn.
Ueda A; Nagao R; Maeda T; Kikuchi K; Murate K; Niimi Y; Shima S; Mutoh T
Clin Neurol Neurosurg; 2017 Oct; 161():14-16. PubMed ID: 28780398
[No Abstract] [Full Text] [Related]
19. Cytokine/chemokine elevation during the transition phase from HSV encephalitis to autoimmune anti-NMDA receptor encephalitis.
Omae T; Saito Y; Tsuchie H; Ohno K; Maegaki Y; Sakuma H
Brain Dev; 2018 Apr; 40(4):361-365. PubMed ID: 29277332
[TBL] [Abstract][Full Text] [Related]
20. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]